Skip to main content
Premium Trial:

Request an Annual Quote

Lynx Extends Service Contract with DuPont

NEW YORK, Nov. 11 (GenomeWeb News) - Lynx Therapeutics said today that it has signed a multi-year, multi-million dollar services agreement with DuPont that extends a five-year agreement the companies initiated in 1998.

Under the extended arrangement, DuPont and its subsidiary, Pioneer Hi-Bred International, will continue using Lynx's Massively Parallel Signature Sequencing (MPSS) technology for the discovery and development of new agricultural traits and products.

Financial details were not disclosed.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.